|
Name |
Azaspirofuran A, FD 838
|
Molecular Formula | C22H21NO7 | |
IUPAC Name* |
8-benzoyl-2-(5-ethylfuran-2-yl)-9-hydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione
|
|
SMILES |
CCC1=CC=C(O1)C2=C(C(=O)C3(O2)C(C(NC3=O)(C(=O)C4=CC=CC=C4)OC)O)C
|
|
InChI |
InChI=1S/C22H21NO7/c1-4-14-10-11-15(29-14)16-12(2)17(24)21(30-16)19(26)22(28-3,23-20(21)27)18(25)13-8-6-5-7-9-13/h5-11,19,26H,4H2,1-3H3,(H,23,27)
|
|
InChIKey |
PXIIDWGMSCTXAQ-UHFFFAOYSA-N
|
|
Synonyms |
Azaspirofuran A, FD 838; 110341-78-1; FD-838; 8-benzoyl-2-(5-ethylfuran-2-yl)-9-hydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione; BS-1196
|
|
CAS | NA | |
PubChem CID | 74966301 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 411.4 | ALogp: | 2.3 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 115.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 30 | QED Weighted: | 0.572 |
Caco-2 Permeability: | -4.734 | MDCK Permeability: | 0.00001680 |
Pgp-inhibitor: | 0.972 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.395 |
Blood-Brain-Barrier Penetration (BBB): | 0.559 | Plasma Protein Binding (PPB): | 93.31% |
Volume Distribution (VD): | 2.361 | Fu: | 4.53% |
CYP1A2-inhibitor: | 0.489 | CYP1A2-substrate: | 0.771 |
CYP2C19-inhibitor: | 0.728 | CYP2C19-substrate: | 0.822 |
CYP2C9-inhibitor: | 0.568 | CYP2C9-substrate: | 0.047 |
CYP2D6-inhibitor: | 0.021 | CYP2D6-substrate: | 0.088 |
CYP3A4-inhibitor: | 0.285 | CYP3A4-substrate: | 0.866 |
Clearance (CL): | 3.255 | Half-life (T1/2): | 0.089 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.265 |
Drug-inuced Liver Injury (DILI): | 0.975 | AMES Toxicity: | 0.144 |
Rat Oral Acute Toxicity: | 0.836 | Maximum Recommended Daily Dose: | 0.032 |
Skin Sensitization: | 0.124 | Carcinogencity: | 0.174 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.023 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003736 | 0.811 | D0J1MI | 0.292 | ||||
ENC002116 | 0.612 | D0E3OF | 0.287 | ||||
ENC003765 | 0.590 | D08UMH | 0.282 | ||||
ENC003742 | 0.590 | D0S7VO | 0.279 | ||||
ENC002724 | 0.590 | D05UWI | 0.279 | ||||
ENC004348 | 0.310 | D0QV5T | 0.277 | ||||
ENC002968 | 0.303 | D08CCE | 0.277 | ||||
ENC003342 | 0.302 | D0H5MB | 0.276 | ||||
ENC004520 | 0.301 | D0Y7RW | 0.275 | ||||
ENC004521 | 0.301 | D0P3JU | 0.272 |